MTOR and neoplasm: Furthermore, we observed a clonal expansion and enrichment of a CD4+ Th1 population exclusively in tumours treated with combination therapy of PI3K/mTOR inhibitors and PD‐1 blockade, implying this T‐cell population is essential in supporting and maintaining CD8+ T‐cell effector function.